This study tests whether a combination of anti-inflammatory and heart-protecting drugs can reduce symptoms and heart damage in people with Long COVID who have ongoing heart inflammation. About 279 adults with heart inflammation seen on MRI will receive either the drug combo or a …
Phase: PHASE3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC